Cyclohexane

Cyclohexane

SCHEMBL2440958

C1CCCCC1.CN(C)c1cccc2onc(C(N)=O)c12

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 5/20 0.38
GAA P10253 3/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
AURKB Q96GD4 5/20 0.34
KIT P10721 2/20 0.34
KDR P35968 2/20 0.34
FLT3 P36888 2/20 0.34
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
CDK8 P49336 1/20 0.34
CDK19 Q9BWU1 1/20 0.34
TP53 P04637 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MET P08581 1/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2309764 0.79 IKBKB (0.40) HIF1AGAATSHRAURKBKIT
Cyclohexane SCHEMBL2440381 0.76 KDM4E (0.39) HIF1AGAATSHRKDM4EMAPT
SCHEMBL30422301 0.74 KCNA5 (0.44) HIF1ATSHRAURKBKITKDR
SCHEMBL2310118 0.72 IKBKE (0.43) HIF1ATSHRAURKBKITKDR
SCHEMBL8250952 0.72 KDR (0.50) GAAKDM4EMAPTAURKBKIT
SCHEMBL2444240 0.72 FAAH (0.47)
SCHEMBL2438379 0.72 HIF1A (0.43) HIF1ATSHRMAPTAURKBSMN1; SMN2
Cyclohexane SCHEMBL2442670 0.71 HIF1A (0.58) HIF1A
SCHEMBL2438808 0.70 HIF1A (0.65) HIF1AKDM4EMAPTKDRSMN1; SMN2
Cyclopropane SCHEMBL2442932 0.69 SCN9A (0.37) HIF1AKITKDRFLT3MET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893589-B1 SUBSTITUTED N-BENZO [D] ISOXAZOL-3-YL-AMINE DERIVATIVES AS INHIBITORS OF MGLUR5, SEROTONINE (5-HT) AND NORADRENALINE RECEPTORS, AND THE USE THEREOF FOR PRODUCING MEDICAMENTS GRUENENTHAL GMBH (DE) 2011-09-14 EP claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US claimed
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof GRUENENTHAL GMBH (DE) 2008-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312301-A1 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof HTR5A, NPY5R, GRM5 HIF1A 2528/4885GAA 4048/4885TSHR 475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.